ESC Premium Access

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Event: ESC CONGRESS 2017
Topic: Thrombosis and platelets
Session type: Satellite Symposium - Experts on the Spot
Sponsored by AstraZeneca
Date: 28 August 2017
Time: 10:15 - 10:45

Session

4 presentations in this session

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)
Thumbnail

Early initiation of dual anti-platelet therapy following an acute coronary syndrome: a clinical case study.

Speaker: Professor S. James (Uppsala, SE)
Thumbnail

Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)
Speaker: Professor S. James (Uppsala, SE)
Thumbnail

Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)
Thumbnail

5 speakers from this session

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
29 presentations
1 follower

Professor Stefan James

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
32 presentations
0 follower

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
29 presentations
1 follower

Professor Stefan James

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
32 presentations
0 follower

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
29 presentations
1 follower

This platform is supported by

logo Novo Nordisk